Latest filing published 18 Mar 2024 for Medpace Holdings, Inc., €39k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ashley M. Keating, listed as board member, appears in our data through filings on Medpace Holdings, Inc. shares, published by SEC (Form 4). We count 7 filings; the first trade dates from 4 August 2021 and the latest from 14 March 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 18 March 2024: an option exercise of €39k, in Medpace Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations